BidaskClub lowered shares of Walgreens Boots Alliance (NASDAQ:WBA) from a strong-buy rating to a buy rating in a report released on Tuesday.

Other equities research analysts have also issued research reports about the stock. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $72.00 target price on the stock in a research note on Tuesday, June 19th. Mizuho set a $77.00 target price on shares of Walgreens Boots Alliance and gave the company a buy rating in a research note on Tuesday, May 29th. Loop Capital upped their target price on shares of Walgreens Boots Alliance to $80.00 and gave the company a buy rating in a research note on Friday, June 29th. Pivotal Research cut their target price on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a hold rating on the stock in a research note on Monday, July 2nd. Finally, Jefferies Financial Group lowered shares of Walgreens Boots Alliance from a buy rating to a hold rating and cut their target price for the company from $85.00 to $65.00 in a research note on Friday, June 29th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $77.22.

NASDAQ:WBA opened at $67.80 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47. The stock has a market capitalization of $68.91 billion, a price-to-earnings ratio of 13.29, a PEG ratio of 1.14 and a beta of 1.10. Walgreens Boots Alliance has a 1-year low of $59.07 and a 1-year high of $83.89.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.06. The company had revenue of $34.33 billion during the quarter, compared to analysts’ expectations of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.33 EPS. sell-side analysts expect that Walgreens Boots Alliance will post 5.97 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 12th. Investors of record on Monday, August 20th will be paid a dividend of $0.44 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. The ex-dividend date is Friday, August 17th. This represents a $1.76 annualized dividend and a yield of 2.60%. Walgreens Boots Alliance’s dividend payout ratio is 34.51%.

In other Walgreens Boots Alliance news, COO Ornella Barra acquired 1,700,000 shares of the company’s stock in a transaction that occurred on Monday, July 16th. The shares were purchased at an average price of $65.15 per share, for a total transaction of $110,755,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the sale, the director now owns 10,943 shares in the company, valued at approximately $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in WBA. BlueMountain Capital Management LLC bought a new position in Walgreens Boots Alliance in the 2nd quarter worth about $103,000. CSat Investment Advisory L.P. bought a new position in Walgreens Boots Alliance in the 2nd quarter worth about $104,000. Alpha Omega Wealth Management LLC grew its position in Walgreens Boots Alliance by 100.0% in the 1st quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 800 shares during the last quarter. Squar Milner Financial Services LLC bought a new position in Walgreens Boots Alliance in the 2nd quarter worth about $106,000. Finally, Archford Capital Strategies LLC bought a new position in Walgreens Boots Alliance in the 1st quarter worth about $115,000. Hedge funds and other institutional investors own 61.99% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: Risk Tolerance

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.